| OPCs | Oropharyngeal cancers |
| HPV | Human papillomavirus |
| OPSCC | Oropharyngeal squamous cell carcinoma |
| ctDNA | Circulating tumor DNA |
| cfDNA | Cell free DNA |
| EBV | Ebstein–Barr virus |
| AUC | Area under curve |
| PFS | Progression-free survival |
| CRT | Chemoradiotherapy |
| PPV | Positive predictive value |
| PET | Positron emission tomography |
| 18F-FDG | 18f-fluorodeoxyglucose |
| FNA | Fine needle aspiration |
| CALML5 | Calmodulin-like 5 |
| YAP1 | Yes-associated protein 1 |
| LY6D | Lymphocyte antigen 6 complex locus d |
| DNAJC5G | DNAj heat shock protein family member c5 |
| EDNRB | Endothelin receptor type b gene |
| EVs | Extracellular vesicles |
| StaVarSel | Stable variation selection |
| MAC | Membrane attack complex |
| CTCs | Circulating tumor cells |
| TRH | Thyrotropin-releasing hormone |
| DDR | DNA damage repair |
| PARP | Poly adp-ribose polymerase |
| HRR | Homologous recombination repair |
| MMP | Matrix metalloproteinases |
| ECM | Extracellular matrix |
| LOXL2 | Lysyl oxidase like 2 |
| NT-3 | Neurotrophin-3 |
| TIMP-1 | Tissue inhibitor of metalloproteinase-1 |
| FAK | Focal adhesion kinase |
| LDH | Lactate dehydrogenase |
| IL-1Ra | Interleukin-1 receptor antagonist |
| BMI | Body mass index |
| MDSC | Myeloid-derived suppressor cells |
| M-MDSC | Monocytic myeloid-derived suppressor cells |
| PMN-MDSC | Polymorphonuclear myeloid-derived suppressor cells |
| TRM | Tissue-resident memory t cells |
| OTSCC | Oral tongue squamous cell carcinoma |
| VEGF | Vascular endothelial growth factors |
| SFlt-1 | Soluble fms-like tyrosine kinase 1 |
| MNCs | Mononuclear cells |
| NLR | Neutrophil lymphocyte ratio |
| OS | Overall survival |